Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RNA polymerase I (Pol I) transcription complex is a specialized multi-subunit assembly located within the nucleolus that is responsible for transcribing ribosomal DNA (rDNA) into the 45S precursor ribosomal RNA (rRNA). This process is the rate-limiting step in ribosome biogenesis, which is essential for protein synthesis and cellular growth (Ruggero & Pandolfi, 2003). The complex is recruited to the GC-rich promoter regions of rDNA by key transcription factors, including the Upstream Binding Factor (UBF) and Selectivity Factor 1 (SL1) (Drygin et al., 2011). In many cancers, Pol I transcription is significantly upregulated to meet the high metabolic demands of rapidly proliferating cells, making it a distinct therapeutic vulnerability (Bywater et al., 2012). Drugs targeting this complex, such as CX-5461, often exploit the high GC content of rDNA by stabilizing G-quadruplex structures, thereby blocking Pol I progression and triggering a nucleolar stress response (Xu et al., 2017). This disruption leads to the activation of p53-dependent and independent apoptotic pathways, providing a selective mechanism to eliminate cancer cells while potentially sparing normal cells with lower ribosome synthesis requirements (Peltonen et al., 2014; Quin et al., 2014).
Inhibition of RNA polymerase I-mediated transcription of ribosomal DNA, often through stabilization of G-quadruplexes in GC-rich rDNA sequences or direct disruption of the Pol I complex assembly and elongation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA polymerase I transcription complex (Pol I transcription complex).